Next Quarterly Earnings
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Shanghai RAAS Blood Products A is a leading Chinese biotechnology company specializing in the research, development, production, and distribution of high-quality blood products. The company focuses on life-saving plasma derivatives like human albumin and immunoglobulins to enhance patient health, playing a central role in China's biopharmaceutical market.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Shanghai RAAS Blood Products A is scheduled to report its next quarterly earnings on 10/23/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Shanghai RAAS Blood Products A last reported quarterly earnings on 8/25/2026 (Q2 2026).
Shanghai RAAS Blood Products A has beaten analyst EPS estimates in 0 of its last 4 evaluated quarters (beat rate: 0%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: 4 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.